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Abstract: Detennining the speciation of selenium in vivo is crucial to understanding the 
biological activity of this essential element, which is a popular dietary supplement due to 
its anti-cancer properties. Hyphenated techniques that combine separation and detection 
methods are traditionally and effectively used in selenium speciation analysis, but require 
extensive sample preparation that may affect speciation. Synchrotron-based X-ray 
absorption and fluorescence techniques offer an alternative approach to selenium 
speciation analysis that requires minimal sample preparation. We present a brief summary 
of some key HPLC-ICP-MS and ESI-MSIMS studies of the speciation of selenium in cells 
and rat tissues. We review the results of a top-down approach to selenium speciation in 
human lung cancer cells that aims to link the speciation and distribution of selenium to its 
biological activity using a combination of X-ray absorption spectroscopy (XAS) and X-ray 
fluorescence microscopy (XFM). The results of this approach highlight the distinct fates of 
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selenomethionine, methylselenocysteine and tenns their speclatlOn and 
distribution within organic selenium metabolites were widely distributed throughout 
the cells, whereas inorganic selenium metabolites were compartmentalized associated 
with New data from the XFM mapping of electrophoretical1y-separated cell "T<l<>T"''' 
show the distribution of selenium in proteins of selenomethionine-treated cells. Future 
applications of this top-down approach are discussed. 
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1. Introduction 
1735 
Organic inorganic selenium compounds are dietary sources of the essential element that is 
critical for the assembly of selenoproteins. 
taken at supranutritional doses [I]. The 
may also reduce the incidence of cancer when 
recommended daily intake of selenium is day for 
women and 60 /lg per day for men (1,2]. Evidence from in vitro studies, animal experiments and 
clinical trials suggest that the biological of are dependent on the speciation of the 
metabolites derived from the ingested selenium compound. In order to fully understand 
mechanisms of the chemopreventative, anti-cancer and biological activities of selenium 
compounds, the relationship between these properties and the chemical form of selenium must be 
understood. As such, the metabolism and speciation of in vivo is an important 
area of research in biology. The advancement of speciation techniques in the last decade has 
led to considerable in the identification of selenium species in biological systems. In this 
review we briefly summarize some recent into in vivo selenium metabolism and "1-", .... ,. ... '-,,, 
based on HPLC-ICP-MS and related techniques; before on the application of 
synchrotron-based X-ray absorption spectroscopy (XAS) and X-ray fluorescence microscopy (XFM) 
to the same problem. 
2. The Selenium Speciation Problem 
selenium-replete diet is one that enables the full expression of selenoproteins; proteins that 
incorporate selenium as selenocysteine (SeCys). In humans, selenoproteins have been identified 
including the antioxidant glutathione peroxidases (GPx), the thioredoxin reductases (TrxR; which are 
redox regulators), the iodothyronine U .... U .... ,.""'"" ... '" that are involved in thyroid hormone metabolism and 
:seleQ()pr,otem P (SelP). which transports to the brain, among functions [3-8]. The functions of 
several other selenoproteins are still poorly defined. There is evidence that selenoproteins can both 
prevent and promote cancer [1,9,10] and it is therefore important to understand the roles of 
selenoproteins in chemoprevention and carcinogenesis. However, the focus this review is on the 
speciation and biological activity Jow molecular weight Se metabolites, which have also been 
implicated in the chemoprevention and mechanisms Se [2,11,12]. The seminal example 
of the of Se supplementation is the Nutritional Prevention of (NPC) Trial. Participants 
the trial received dietary supplements the form of selenised yeast tablets resulting in a reduction 
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the incidence of prostate cancer in total cancer incidence [1 5]. The Se 
level of almost aU of the NPC Trial participants was above that observed to result in maximal 
expression of plasma selenoproteins [14], which that benefits associated with 
supplementation may be from low molecular weight Se metabolites. 
positive outcomes of the NPC Trial generated impetus for a The and 
Vitamin E Cancer Prevention Trial (SELECT) provided participants with the same dose as in the 
NPC Trial (200 )lg Se/day) in order to test whether it could prostate cancer. Selenomethionine 
(SeMet) was as the fonn of Se supplementation in the trial over selenised yeast, and 
monomethylated selenium compounds (e.g., methylselenocysteine or methylseleninic acid) that were 
also considered [12,16,17]. was discontinued when analysis showed no benefit, nor any 
prospect of benefit, from Se or vitamin E supplementation alone, or combination [18,19]. 
Several hypotheses have been proposed to explain the different outcomes of and NPC 
[20-23]: The choice of SeMet the supplement is one them [13,24,25]. SeMet is a major 
component of selenised yeast, but the yeast tablets used in the NPC Trial contained other 
selenium compounds in addition to SeMet, such as methylselenocysteine (MeSeCys), that may be 
more effective chemoprevention [26-29]. It is understood that the biological activities associated 
with are dependent on the chemical speciation of Se, but it is not known which selenium 
compounds are most efficacious in cancer prevention; nor are the chemopreventative 
mechanisms of Se fully established. Therefore, identifying the metabolic products of different fOnTIS of 
Se in vivo and understanding relationship between the ingested form of its metabolites and their 
biological activities is crucial to explaining the anti-cancer effect of 
2.1. Dietary Selenium Compounds and Their Metabolites 
The current of metabolism has been developed over several decades [13,30], with 
most metabolites initially identified 
through indirect methods. More 
by ICP-MS 
molecular mass spectrometry [3 
presented in Figure 1. 
in vitro chemistry studies or in cell-free tissue homogenates 
many metabolites been identified mammalian 
but only a few been unambiguously identified by 
structures of Se compounds pertinent to this review are 
The most commonly dietary selenium compounds are selenite, SeMet and MeSeCys. Each 
of these compounds follows a different metabolic route to a presumed common intermediate, from 
which the selenoprotein synthesis and the Se excretion pathways originate, as shown in 2. The 
excreted methylated metabolites are the most readily analyzed and dimethylselenide (DMSe), 
established as the major Se excretory metabolite in breath, was first identified as early as 
the 19505 [34,35]. Trimethyiselenoniurn (TMSeJ was first identified in rat urine in 1969 [36,3 and 
was considered the major urinary metabolite until the identification of selenosugars in urine by 
HPLC-ICP-MS and ESI-MSIMS 2002 [13,38-40]. The late Suzuki and co-workers used 
HPLC-ICP-MS conjunction with radiolabelling to investigate the efficiency of methylation and 
demethylation steps in rat tissue and supernatants incubated with selenium 
compounds [38,41]. By the generation of methylated excretion products and ",",l'vU~J"u",a! 
they made inferences about the relative efficiency of putative methylselenol (MeSeH; 
Nutrients 2013, 5 1737 
monomethylselenolate, MeSe- at physiological pH [42]) generation by selenium compounds [43,44]. 
The ability to generate MeSe - may be crucial to the anti-cancer properties of seleniwn compounds [45,46]. 












































Figure 2. An overview of the metabolism of the dietary selenium compounds selenite, 
SeMet and MeSeCys. See text for references. 




The dietary selenium compounds share some metabolic pathways: the methylation and selenosugar 
excretory pathways, and the production of selenoproteins. The metabolic routes to the presumed 
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common selenide intermediate, however, differ with Se speciation. As seen for the excreted 
metabolites, hyphenated techniques that combine separation and detection methods are the techniques 
of choice for the identification of non-excreted metabolites. However, the identification of low 
molecular weight selenium compoWlds in cells and in vivo has proved a chalJenge for speciation chemists. 
Inorganic selenite is reduced by glutathione (GSH), TrxR and the thioredoxin and glutaredoxin 
systems to selenodiglutathione (GSSeSG). GSSeSG is further reduced via a selenopersulfide (GSSeH) 
to hydrogen selenide (HSej by the same systems [3,5-8,47]. GSSeSG has been identified by 
HPLC-ICP-MS in spiked rat liver cytosols [9,48] and by ESI-MSIMS in cell culture [11 ,49J, but the 
volatility and reactivity of the intennediate GSSeH and product HSe- make their in vivo detection 
difficult. Speciation analysis of selenite-treated lung cancer cells by Lun.0e et al. revealed that a 
significant proportion of Se was bound to protein while the remainder was unchanged [13,50]. The 
nature of the Se bonding within the protein fraction was not explored. 
The Se analogue of methionine (Met), SeMet, has been shown, in rat liver homogenates, to be 
metabolised to SeCys via the trans-sulfuration pathway [51,52]. SeCys can then be cleaved by p-Iyase 
to HSe- [16,53]. In addition, SeMet can be adventitiously incorporated into proteins in place of 
Met [18]. A third pathway is open to SeMet in its cleavage by y-lyase to MeSe-, although the extent to 
which this pathway operates is uncertain [20,22,48]. In a number of cancer cell lines, 
LuruJe et of. [13,54] found that SeMet largely remained intact and did not react with cytosolic proteins. 
Another selenoamino acid, MeSeCys, has a metabolic pathway distinct from that of SeMel, in that 
its major metabolite is MeSe-, generated by ~-lyase cleavage of the amino acid [26,55]. In some cancer 
cells, MeSeCys was largely unrnetabolised, with the generation of dimethyldiselenide (DMeDSe) 
alone suggesting the generation of MeSe-, although MeSeCys was comparatively non-toxic to the 
cells [13,56J. Tsuji et al. [31,57] found that long-term ingestion of MeSeCys by rats led to Se 
accumulation in the kidney, liver and testes, selenoprotein synthesis and the excretion of TMSe + and. 
selenosugars in urine, in accordance with the prevailing model of Se metabolism [34J. 
Methylseleninic acid (MeSeA) is a simplified fonn of MeSeCys that is readily reduced to MeSe - in 
the absence of J3-lyase [36]. As such, it is often used in place of MeSeCys in in vitro and cell culture 
experiments. MeSeA has been shown in cancer cells to generate MeSeCys, y-glutamyl-MeSeCys and 
DMeDSe, and to interact with proteins [13,38,58]. In addition, the identification of SeMet in 
MeSeA-treated cells suggests the existence of a currently unknown metabolic pathway that warrants 
further investigation [38,59]. 
2.1 .1. Hyphenated Techniques and Selenium Speciation 
A comparative study of the metabolism of selenite, SeMet and MeSeCys in rat tissues, each labeled 
with a different stable isotope of Se, is a typical example of the application of hyphenated 
techniques [60,61]. SeMet and MeSeCys were found to be transported to organs unchange~ but 
selenite was metabolised before reaching the organs. All of the selenium compounds contributed to 
SelP production, but selenite was most effective, followed by SeMet and MeSeCys. Finally, based on 
the differing abilities of each of the selenium compounds to produce TMSe + and selenosugars in the 
liver and kidneys, the authors were able to argue that the metabolism of MeSeCys was distinct from 
both SeMet and selenite metabolism; supporting the current model of Se metabolism that suggests 
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MeSeCys is the most important generator of MeSe-. Still, some metabolites remained unidentified and 
the speciation of low molecular weight selenium compounds that between the dietary compounds 
and tbe excretory compO\mds was not determined. 
The hypbenated techniques bave been extensively applied to analysis of speciation in food 
and selenised yeast [43] and in animal models and human body fluids [45J However, while offering 
excellent sensitivity to trace compounds and the ability to separate and unequivoca.lly identify 
individual compounds, these techniques have the disadvantage of requiring extensive sample 
preparation (including digestion, extraction and separation steps) of cells tissues. digestion 
and acidification of samples can alter the chemistry of Se, particularly in regards to its oxidation 
state [47,62]. while the speciation of Se in different tissues can be ascertained, 
information on the distribution of Se within 
An to hypbenated techniques is 
distribution information. 
is lost in the homogenization of samples. 
to provide unadulterated in vivo Se speciation 
3. Synchrotron-Based X-ray Techniques in Elemental Speciation Analysis 
Synchrotron-based techniques are a viable alternative to hyphenated techniques in elemental 
speciation analysis. The brilliant, penetrating, high-energy X-rays produced by a synchrotron can be 
tuned to probe a sample for a element; taking advantage the characteristic binding 
of core electrons in the atoms of each element. In X-ray absorption spectroscopy (XAS), a spectrum, 
similar to a UV/vis spectrum, is generated by across an energy range above and below the 
absorption edge (the at which core electrons are excited) of An absorption 
near structure (XANES) spectrum is collected within about 100 eV of the absorption 
edge [48,63,64] as the core electron is excited to a higher energy level. In biological samples, where 
the of the of is usually low high sensitivity is required, the 
fluorescent photons, emitted as higher energy electrons fill the core electron shell, are collected to 
generate the XANES spectrum. The XANES spectrum the average coordination environment 
and oxidation state of the ,\.IuJ, .... ,,, of interest. 
At even higher energies above the absorption edge, the core electrons are the atom and 
interact with neighboring atoms to generate an oscillating pattern the spectrum-the extended X-ray 
absorption fme structure (EXAFS). The coordination number of bound atoms can estimated 
(±20%) EXAFS spectrum and bond can be determined to witbin 0.02 A, although 
atoms of similar atomic number (e.g., N and 0) cannot normally be distinguished [49,65J. A single 
energy scan of a sample can provide a single spectrum containing both XANES and EXAFS, wbich 
can analyzed to determine the of element of interest. XANES 
are analyzed by fitting a linear combination of model compound spectra to the sample spectrum, while 
EXAFS spectra can be analyzed a priori. 
lOTi~SCem photons that are used to create an XAS spectrum are also the basis of X-ray 
fluorescence microscopy (XFM). Instead scanning across an energy (as per in XFM 
the is held constant above the absorption edge and the position of the sample is scanned to 
create an elemental based on the intensity of fluorescence at each Crucially, the energy 
used to the element of interest will also excite elements with atomic numbers lower than that 
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element. Thus a number of elemental maps are generated simultaneously, although the sensitivity to 
elements at low atomic numbers decreases as the incident energy increases (typically we detect down 
to sod;um). In addition to mapping the distributions of individual elements across cells and tissues, 
spatial relationships between elements can also be identified and by comparison to elemental 
standards, the concentrations of the elements can be determined. 
In recent years, and XFM, separately and combination, have been applied to the study of 
metals and non-metals heavier than Si biology. XAS and XFM were used to show that silver was 
bound to in some marine mammals and sulfur in others, probably as a detoxification 
mechanism [50,66]. et ai. (51,64] studied the speciation of methylmercury in human brain 
from individuals with varying levels of mercury and found, using XAS and that 
Se may playa in mercury detoxification. and XFM are popular in 
the field of bioinorganic chemistry-a recent tutorial review offers an overview of the application of 
XAS to biological samples and some XFM biology are reviewed by 
Fahmi [68,69], while the application of both XAS and XFM to the study of metal-containing drugs 
reviewed by Aitken et al. [48]. 
The Use of Synchrotron-Based X-Rays to Investigate Selenium in Biology 
1J ........ UL .• Vll and distribution biological samples is particularly amenable to XAS and 
XFM techniques. XANES spectra of organic compounds are distinct each and from 
inorganic selenium compounds, which allows for linear combination fitting of mixtures of selenium 
compounds found in biological samples [54]. However) in comparison to hyphenated techniques, XAS 
is disadvantaged by lack of sensitivity at low ...... "LV'""" ....... " its inability to detect trace 
components. It is limited to determining the coordination and oxidation environment of Se, rather than 
the exact identity of the selenium compound. Care must also be taken to prevent photo-reduction of 
selenium compounds high oxidation states [55]. The of XAS include the ability to 
collect two independent sources of information from XAl'ffiS and spectra and the ability to 
apply the same technique to a variety samples with very minimal sample preparation. All selenium 
compounds, protein-bound, hydrophobic or can be interrogated without need for 
multiple extraction and separation procedures, using a single sample preparation method. 
The simultaneous mapping of biologically relevant elements in intact biological samples, allowing 
for the observation of relationships between different elements) is a of XFM. Tbe atomic 
number of Se (Z = 34) and its corresponding Is ionization energy it ideal for elemental mapping 
as the endogenous elements S, CI, K and Ca are all mapped simultaneously. Importantly, the 
transition metals Fe, Cu and with of their core electron not much lower than are 
also mapped with good sensitivity. In combination, XAS XFM provide complimentary 
information on elemental speciation and distribution that can provide novel information, drive new 
and can be applied to in vitro biological fluids, cells tissues 
Several investigators have applied either XAS or XFM to the study of Se biology. 
Wang et al. (56] showed that CU(I) binds to selenoamino acids in phosphate buffer, using both 
Se K-edge and Cu K"edge XAS to the bonds addition to NMR and OFT studies. 
A natural extension of this study would be to attempt to identify and characterize this interaction in 
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cells : a study to which XAS is well-suited. The speciation of Se in Se-enriched yeast was investigated 
using both XAS and HPLC-ICP-MS where the results from each technique were in agreement, 
although the restricted model compound library and absence of an EXAFS spectrum limited the 
information that could otherwise be derived from XAS [57]. XANES has been applied to the study of 
Se metabolism in rainbow trout hepatocytes exposed to selenite, selenate or SeMet [70] and extended 
to the determination of Se speciation in tissues from rainbow trout exposed to SeMet [71]. 
The localization of Se in a neuronal cell model, treated with the Se drug ebselen, was observed 
using XFM [58). The technique revealed the effects of ebselen on Mn, Fe, Cu and Zn homeostasis in 
addition to Se distribution. Gladyshev and coworkers have used XFM of tissues from knock-out and 
wild-type animals combined with traditional immunohistochemical techniques to investigate the roles 
of selenoproteins. In addition to mapping the distribution of Se in spermatids, the roles of 
mitochondrial GPx4 and SelP in mouse spennatogenesis were unraveled using XFM in coordination 
with traditional biochemical techniques [59]. Similarly, the distributions of Se in mouse liver and the 
kidneys of mice and naked mole rats were mapped using XFM to reveal relationships between tissue 
levels of Se and the expression of GPxl, GPx3 and SelP [60]. In a rat model of myoglobinuria, XFM 
was used to show a relationship between Se distribution and GPxl in the kidneys of rats fed a high-Se 
diet as selenite [72]. XAS and XFM, in combination with other speciation, chemical and biochemical 
techniques can clearly be applied to a wide variety of systems and problems involving Se. 
4. A Top-Down Approach to Investigating Selenium in Biology 
Herein, we present a top-down approach to the investigation of Se in biology: studying the 
speciation of metabolites of supranutritional doses of selenium compounds in human cancer cells, 
using XAS and XFM techniques that, in combination, provide insight into the speciation and 
distribution of Se in bulk and single cell samples. The nature of each X-ray technique dictates the type 
of sample that can be interrogated. The X-rays available at X-ray absorption beamlines are typically 
delivered in beams on the order of millimeters in width to provide sufficient photon flux for the 
collection of XANES and EXAFS spectra. Thus, bulk cell samples, containing approximately 
105-106 cells [73], are required for XAS measurements. The XANES and EXAFS spectra from those 
bulk samples are averages of all of the regions within all of the cells. In contrast, XFM beamlines are 
designed to produce beams from a few hundred nanometers to a few micrometers in diameter allowing 
the elemental mapping of single cells at sub-micron resolution. XAS may also be collected from 
samples at some XFM beamlines, thereby providing localised chemical speciation information, 
although the low concentrations and lower flux (relative to the larger, traditional XAS beams) result in 
low resolution spectra. As such, microprobe-X AS (~-XAS) techniques are limited to regions with high 
concentrations of the element of interest. The combination of bulk XAS, ~-XAS and XFM techniques 
is capable of providing bulk and localised speciation information as well as elemental distributions in 
single cells. 
4.1. Selenium Speciation Dictates Distribution in Human Lung Cancer Cells-Findings from XFM 
Human cancer cell lines, which are more sensitive to Se than nonnal cells [62], are relevant models 
for the study of the biological activities of Se metabolites. As they are more complex than in vitro 
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systems, but less complex than animal models, they are appropriate model systems for the fIrst 
application of our top-down approach. XFM revealed that Se distribution in A549 human lung cancer 
cells is dependent upon the speciation and concentration of the selenium compounds with which they 
are incubated (Figure 3), which supports the model of distinct metabolic pathways of dietary selenium 
compounds [63,64,74]. It was observed that SeMet-treated cells readily accumulate Se: after 24 h 
a 70-fold increase in Se versus vehicle alone control cells was observed in 10 ~M SeMet-treated cells 
and a 270-fold increase was observed in 50 JlM SeMet-treated cells. Fifty micromolar 
MeSeCys-treated cells, despite the much higher toxicity of MeSeCys to the cells than SeMet, 
contained only four-fold more Se than control cells. In the resulting Se elemental maps the cells were 
virtually indistinguishable from the background (similar to what was observed in maps of control 
cells). In stark contrast, elemental maps of SeMet-treated cells showed that Se was present throughout 
the cells with a strong accumulation in the perinuclear region (indicated in Figure 3a). The perinuclear 
accumulation was a feature shared with sulfur that, given the ability of SeMet to be adventitiously 
incorporated into proteins in place of methionine, suggests that this perinuclear Se accumulation may 
be in the endoplasmic reticulum, a site of protein synthesis. 
Figure 3. Optical micrographs (top left), scattered X-ray (XS) and XFM elemental 
distribution maps of A549 cells treated with (a) 50 ~M SeMet (the white arrow indicates 
the perinuclear accumulation of Se), (b) 50 JlM MeSeCys or (c) 5 JlM selenite. The range 
of elemental area densities (quantified from standards and expressed in micrograms per 
square centimeter) is given in the bottom comer of each map. 
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The difference in the Se contents of the SeMet- versus the MeSeCys-treated cells may be explained 
by a difference in speciation and metabolism. Volatile metabolites produced by MeSeCys-treated cells 
may have escaped (a hypothesis that fits with the observation of volatile DMeDSe forming in the head 
space of hepatocytes incubated in MeSeA [65]) or, during sample preparation, Se species present in 
MeSeCys-treated cells may have been washed out, but the Se species present in SeMet-treated cells 
were not. The latter explanation points to the importance of sample preparation in XFM. Although 
sample preparation is minimal compared to the preparation required for HPLC-ICP-MS, it may still 
interfere with the sample by selectively mobilizing and redistributing or washing out metals and this 
possibility must be considered when analyzing XFM data, as emphasized by the chemical alterations 
that have been observed in formalin-fixed versus cryofixed brain tissues [66]. 
The most distinctive Se distribution was observed in selenite-treated cells. Selenite is the most toxic 
of the three selenium compounds discussed here. The IC so of selenite at 72 h (5 ).1M) in these human 
lung cancer cells is 20- to 100-fold lower than the IC50s of MeSeCys and SeMet, respectively [64]. 
Twenty-four hours selenite treatment at 1 J..lM resulted in a Se concentration that was almost 
indistinguishable from background levels. However, a 5 flM selenite treatment resulted in a 250-fold 
increase in Se, similar to that observed in 50 IlM SeMet-treated cells, but with a very different 
distribution. Selenium was found to have accumulated in many small regions (a few microns in 
diameter) in the cytosoL In addition, Cu was found to share this punctate distribution and undergo a 
two-fold increase in concentration, which suggested that Cu is either complicit in the cytotoxic 
mecbanism of selenite or is part of a cellular defense mechanism against selenite-induced toxicity. 
Recent work suggests that the increased Cu concentration is due to the upregulation of SOD I in 
response to increased ROS generation that occurs 24 h after selenite treatment [75]. 
Copper sulfate has previously been found to prevent Se toxicity when provided to cells [67] and 
rats [68J at the same time as selenite, but this was the first observation of a Cu and Se association in 
cells treated with selenite alone. The observation of the Se and Cu accumulation in selenite-treated 
cells patently demonstrates the usefulness of XFM in generating multiple elemental maps: the 
destruction of samples inherent in the use of hyphenated techniques means that these types of 
elemental associations, where the associated elements are not necessarily bound within the same 
compound, cannot be identified by these techniques. 
4.2. Selenium Speciation in Bulk Cell Pellets and Single Cancer Cells 
Speciation information from XAS augments the distribution information from XFM and helps to 
explain why Se distribution differs between cells treated with different dietary selenium 
compounds [63,64,74]. XANES and EXAFS spectra both show that SeMet- and MeSeCys-treated 
cells have speciation profiles that are completely distinct from the speciation profile of selenite-treated 
cells. Fits to EXAFS spectra are generated a priori, but fits to XANES spectra require a model 
compound library. Our model compound library, shown in Figure 4, covers the most likely Se 
coordination environments in biology, which are clearly distinguishable based on the coordination 
environment and oxidation state: Se-Se--Se, S-Se-S, R-Se--R, R-S~e-R, R-8e-, O-So-O, 
R-Se-S-R. The models used to fit the experimental XANES spectra are drawn from the library after 
principal component analysis and target transfonnation indicate the number and type of model 
Nutrients 2013, 5 1744 
compounds to use in the multiple linear regression analysis. As mentioned earlier, XANES indicates 
the coordination environment of the Se atom, but does not identify specific Se species. Comparison of 
SeMet, MeSeCys and SeCys XANES spectra, for instance, attests to the similarity of the spectra 
produced by different selenium compounds with the same coordination environment around the Se 
atom. Thus, the three amino acids are collectively considered R-Se-R compounds, as it is unlikely that 
a mixture of these compounds can be reliably deconvoluted by linear combination fitting. 
Figure 4. Library of Se K-edge X-ray absorption spectra of model selenium compounds 
used in the linear combination fitting of experimental spectra. XANES spectra of cells 
treated with 100 j.LM SeMet (blue), 100 j.LM MeSeCys (red) or 5 j.LM selenite (orange) are 
also shown for comparison. 
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SeMet-treated A549 bulk cell pellets were shown by XANES and EXAFS analysis to contain 
carbon-bound Se species as did the perinuclear region of the cells when probed by j.L-XANES (while 
noisy, direct visual comparison of these spectra to model compounds clearly showed they shared their 
key features with R-Se-R models) [63]. Taken together, these data suggest that roost of the Se in these 
cells is found protein-bound as SeMet or SeCys. XANES fitting revealed that R-Se-R species 
constituted 800/0-85% of the Se in MeSeCys-treated cells, with the remaining 15%-20% composed of 
a diselenide species. The concentration of Se in the cells was too low to confirm with EXAFS, 
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highlighting the low sensitivity of this technique and so the experiment was repeated in SH-SY5Y 
human neuroblastoma cells, in which was more highly concentrated and to which MeSeCys 
was [74]. The XANES results reflected those found in the corresponding A549 
850/0-90% R-Se-R and 100/0-15% R--8e-Se-R-and were supported hy the results of 
analysis, which clearly a scatterer with a bond A in addition to 
carbon scatterers at a bond length of 1.96 A. By comparison, a Se-C bond was the only 
contribution to the spectrum ofSeMeHreated SH-SYSY cells. 
The of diselenide species the MeSeCys-treated cells, but not SeMet-treated cells, 
that MeSeCys generates metabolites that alter the redox balance of cell to a more 
oxidising environment, but SeMet not The implication, based on the accepted Se metabolism 
pathway is that MeSeCys is a better of the putative reactive oxygen species (ROS) generator, 
MeSe [76]. Methylselenol (R-Se-HIR-Se-) is not present in our model compound library, but would 
be expected to have a similar spectrum to SeCys, which is included in the library in its protonated 
(R-Se-H) and deprotonated fonn (R-Se-); is predominant at physiological pH [77]. 
A diselenide, DMeDSe, been identified by 
metabolite of MeSeA-treated rat hepatocytes [65] and by 
inlet mass spectrometry as a volatile 
chromatography and mass spectrometry 
MeSeA-treated human lymphoma [38J, but diselenides were not identified within cells. The 
presence of diselenide within the A549 cells indicate the presence of DMeDSe and/or the 
oxidation of selenols within the cells, the latter possibility having implications for protein function. 
predominantly R-Se-R speciation of in the selenoamino acid-treated is in contrast to 
the mostly inorganic species observed in cells with 5 ~M selenite in A549 cells [64]. After 1 
all of the selenite had been metabolised, contrary to what LUMe et af. (1 found prostate, colon and 
leukemia cancer cens, but accordance with the in vitro chemistry, the abundance of in cells 
and findings from an animal model [61]. The presence of and elemental species after 
24 h conforms to the reductive metabolism pathway observed in vitro. Previously, Se had 
not been identified in cells, which may due to its large insoluble 
Se of selenite-treated rat hepatocytes was observed by Gabel-lensen et al. [78], which 
LC-ICP-MS is incapable of analyzing. HSe- was not identified in the XANES spectra of these, or the 
SeMet- or MeSeCys-treated cells, which suggests that, at best, it is a very minor component «5%) of 
the cells, in keeping with reactivity and volatility. 
In addition to the and elemental species, which were identified in both XANES and 
EXAFS spectra of cells, R-Se-R and diselenide were identified in XANES 
" ...... ,,...1"1-':1 (oscillations the due to carbon scatterers are expected to overwhelmed by the 
heavy and abundant Sand scatterers in the sample). Notably, the proportion of the organic and 
diselenide species changed significantly between and 48 h when the proportion of I'\'.-;~e-·K 
the proportion of increased, a change to a more 
environment that coincided with a substantial decrease in cell viability. single cells imaged by 
XFM were on the precipice of this change, which points to the importance of the distributions of Se 
and the cells. From the regions of accumulation, ~-XANES spectra were collected and 
comparison to model compound spectra revealed that these regions were composed predominantly of 
Se (and perhaps species), which, nano-sized, is considered biologically 
The Se concentration outside of these regions was too low to collect XANES spectra, but it can be 
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inferred from the bulk XANES results that the organic speCIes and diselenides dominate in the 
remainder of the cell. 
Selenite is known to induce the generation of the superoxide anion radical and other ROS in 
cells [79,80]. Our recent work (unpublished data) indicates this is the case in 5 JlM selenite-treated 
A549 cells and suggests that SOD! is upregulated in response to selenite insult, supporting the 
hypothesis that the response of Cu to selenite insult is part of a protective mechanism against oxidative 
damage. The possibility of eu directly bonding to Se in the cells was considered and tested by 
attempting to fit Cu and Se scatterers to Se EXAFS and eu EXAFS of the cells, respectively. There 
was no evidence of Cu bonding in the Se EXAFS and the presence of Se in the Cu EXAFS was 
ambiguous [75]. Moreover, despite its presence in the model compound library, CuSe was not a 
component of the Se XANES spectrum. Taken together with the fact that the increase in Cu was much 
less than the increase in Se, we are confident that the colocalisation of Se and Cu in the selenite-treated 
cells is not due to any significant intraceUular Cu-Se bonding. 
Though limited in its sensitivity and ability to fully identify Se metabolites, XAS in combination 
with XFM has enabled us to identify links between speciation, distribution and biological activity that 
could not be identified using the traditional hyphenated techniques. 
4.3. Extending XFM to Selenium in Electrophoretically-Separated Cell Lysate.s 
Imaging of single cells with XFM reveals the spatial distribution of elements, but by combining 
electrophoresis with XFM, the distribution of elements amongst proteins can be observed. 
Finney et al. [81] recently demonstrated the application of XFM to electrophoretically-separated 
proteins using two examples: investigating the binding of Cr to blood serum proteins in vitro, with the 
application of )l-XANES to determine Cr speciation; and examining the effects of oxygen depletion on 
the speciation of Fe in a bacterium. The combination of these two techniques has the potential to help 
identify new roetalloproteins [82] and investigate the effects of changing conditions on the binding of 
metals by proteins. 
The challenges in conducting XFM of electrophoretically-separated metalloproteins have been 
well-described by Finney et al. (81), particularly with respect to the difficulty in maintaining 
non-covalent bonds between metals and proteins while achieving good separation using native-PAGE. 
The benefits of working with Se in this context is that we expect that the majority of, if not all, Se 
associated with proteins to be bound covalently and so the traditional SDS-PAGE technique, in which 
detergents, reductants and chelators are used to denature proteins, can be used without trepidation. 
Nonetheless, it would be of interest to detennine if other metals are associated with Se-containing 
proteins and so minimally disruptive SDS-PAGE (avoiding heating, reductants and chelators, but using 
some detergent) and native PAGE may still prove useful. Here, we present the first example of XFM 
imaging of Se in electrophoretically-separated cell lysates. 
For a full description of the experimental methods see Supplementary Information. Briefly, 
A549 cells were treated with SeMet, MeSeCys or selenite for 24 h, lysed with either SDS-containing 
or native lysis buffer, applied to 40/0-20% gradient Bio-Rad mini-PROTEAN TGX gels and separated 
electrophoretically before blotting onto a PVDF membrane using a wet transfer system. All solutions 
were made using Milli-Q water and Teflon tweezers were used to prevent metal contamination. 
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The gels were prepared in duplicate with one stained with Ponce au S to visualize proteins, while the 
other remained unstained for XFM. bnaging was performed at beamline 8-BM-B at the Advanced 
Photon Source, Lemont, IL, USA. The X-ray beam was tuned to 12.8 keY and passed through a 
pinhole. Full X-ray spectra were collected by a four-element silicon drift detector (Vortex, sa 
Nanotechnology, Northridge, CA, USA) every 0.5 mm step over a 2 s dwell time. Spectra were fitted 
and images were processed using MAPS software (83]. 
Figure 5. Photograph (top right) and XFM elemental distribution maps of S, Se and an 
overlay of S and Se in an SDS-PAGE blot of the lysates of cells treated with selenium 
compounds for 24 h. The wells contain Iysates of cells treated with (a) 5 f.LM selenite, 
(b) PBS alone (as vehicle control), (c) 50 ~M MeSeCys, (d) 50 ~M SeMet, 
(e) 1 /lM selenite or (f) 100 ~M SeMet. The color scheme indicates the relative 
concentration within each elemental map. 
Selenium was detected in the lysates of SeMet-treated cells separated by SDS-PAGE (Figure 5), 
minimally disruptive SDS-PAGE (Figure SI) and native-PAGE (Figure S2), but Se was not detectable 
in either MeSeCys- or selenite-treated cell lysates, despite some of those wells containing similar or 
greater protein levels (as judged by visual comparison of the intensity of the staining and sulfur maps 
of each well) than the SeMet-treated celllysates. No metals were detected within the protein bands on 
any of the blots, which may indicate that the native-PAGE conditions used were not adequate for 
retaining metal -protein bonds or that the levels of metaUoproteins were not detectable. The Se present 
in the SeMet-treated cell lysates must be covalently bound in either SeMet or SeCys residues, as 
expected from the metabolic pathway of SeMet, the results of XAS speciation analysis of whole cells 
and the conditions of SOS-PAGE. The ubiquitous presence of Se in proteins from 15 to 250 kDa in 
size suggests that SeMet has been adventitiously incorporated into protejns that, under nonnal 
circumstances, contain Met, in keeping with the hypothesis drawn from the observation of an 
association between Se and S in intact SeMet-treated cells. The inability to detect Se in the other cell 
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lysates has three possible explanations: (1) MeSeCys and selenite are predominantly metabolised into 
low molecular weight selenium compounds, such as the elemental Se identified in selenite-treated 
cells; (2) selenoproteins, even in cells with high levels of Se, are below the detection limit of the 
technique and the high levels of Se in SeMet-treated cell lysates are due only to the adventitious 
incorporation of SeMet into proteins; or (3) Se is non-covalently bound to MeSeCys- and 
selenite-treated cell lysates and was cleaved even during native-PAGE. 
The qualitative experiment described above is a proof of concept that, at least in SeMet-treated 
cells, Se can be detected by XFM in cell lysates. By increasing the protein concentration and 
experimenting with treatment concentrations and optimizing electrophoresis conditions and with the 
continued improvement of beamlines adapted to this experiment, it may be possible to detect 
selenoproteins in the lysates ofMeSeCys- and selenite-treated cells. The combined electrophoresis and 
XFM technique is already being expanded into 2D gel electrophoresis [82], and thus has the potential 
to be applied to the discovery of metals associated with selenoproteins or Se associated with proteins. 
5. Conclusions 
A simplistic view of the Se metabolic pathway would seem to suggest that all Se compounds 
eventually produce the same metabolites and could be considered equal, but we know that dietary 
selenium compounds have disparate abilities to generate different Se metabolites-both those 
considered key metabolites, such as MeSe -, and metabolites currently held to be biologically inert, 
such as elemental Se. Thus, the ability to identify and measure metabolites of dietary selenium 
compounds in vivo is crucial to our understanding of the biological activity of these potentially useful 
compounds. The results of our XAS and XFM experiments clearly demonstrate the distinct cellular 
fates of SeMet, MeSeCys and selenite. 
In comparison to the traditional hyphenated techniques used in Se speciation analysis, XAS lacks 
sensitivity and the ability to fully characterize Se species. However, the combination of XAS and XFM 
techniques is able to provide unique insights into the relationship between Se speciation and 
distribution and biological activity, with the important advantage of requiring minimal 
sample preparation. 
The findings of our combined XAS and XFM studies summarised in Table I show that some key 
properties of dietary selenium compounds, previously studied in vitro, are upheld in intact cells 
subjected to minimal sample preparation, these properties are: (1) the speciation and distributions of 
the investigated dietary selenium compounds within cells are distinct from each other, (2) metabolites 
of MeSeCys and selenite significantly modify the redox status of cells, whereas SeMet does not and 
(3) selenite follows the reductive metabolism pathway to elemental selenium. More generally, our 
results show that organic Se metabolites (R-Se-R species) are readily accumulated and distributed 
widely through the cell, probably as a result of their adventitious or specific incorporation into 
proteins, whereas the inorganic Se metabolites (elemental Se and possibly S-8e-S) are 
compartmentalized, which may be due to their toxicity or lack of a specific cellular export mechanism. 
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Table 1. A summary of the speciation and distribution of Se in human lung cancer cells 






Speciation of Se metabolites 
R-S~R 
mostly R-Se--R 
signi ficant R-S~Se-R component 
elemental Se, S-Se-S and R-Se-Se-R 
some R-Se-R 
Distribution of Se metabolites 
throughout the cells, but particularly concentTated in 
the perinuclear region 
bound to proteins 
uncertain 
elemental Se concentrated in small regions throughout 
the cytosol 
Se associated with, but not bound to, Cu 
It is clear that these complimentary XAS and XFM techniques can be usefuJly applied to the 
problem of Se speciation, leading us to ask new questions and reiterating the need to address extant 
questions in Se metabolism: is the S and Se colocalisation in the perinuclear region due to adventitious 
incorporation of SeMet, and if so what are the consequences for these proteins and the cell? (A recent 
study of SeMet incorporation into amyloid sequences shows that it affects the self-assembly and 
toxicity of the sequences, suggesting that the level of SeMet incorporation into proteins could have 
consequences, positive and negative, in vivo [84).) What volatile or mobile metabolites have been lost 
from the MeSeCys-treated cells and are these important in understanding the biological activity of 
MeSeCys? Is the increase in and colocalisation of Cu with Se part of a defensive response to the insult 
of selenite metabolites? Where is elemental Se being compartmentalized and does it play any role in 
the toxicity of selenite towards cancer cells? 
Questions will multiply as this work is extended in vivo: while determining speciation in intact cells 
is an improvement on cell-free models, selenium compounds can be metabolised in bodily fluids and 
their metabolism varies between organs [61]. The obvious extension of this work is into animals and 
models of disease, and while these more complex systems will pose fresh challenges, the sample 
preparation will remain minimal and the collection and analysis of the spectra and images will remain 
essentially the same. We have begun to extend our work into this area with the XFM investigation of 
Se distribution in the kidneys of rats subjected to a model of myoglobinuria [72]. 
XAS and XFM techniques continue to advance with improvements to hardware and software, and 
further development of the techniques. Faster detectors allow the mapping of larger areas at higher 
resolution with smaller beams on the order of nanometers to probe subcellular structures. 
Developments in analysis software and techniques improve and expand the information that can be 
gleaned from XFM data. The mapping of chemical speciation, the ultimate integration of XAS and 
XFM techniques, has already been demonstrated in the mapping of organic and inorganic Se species in 
plants [85] and also in the mapping of several different S species in plants [86] and is clearly suited to 
the mapping of Se species in mammalian systems. Hardware and software improvements are making 
speciation mapping more accessible as well as allowing the mapping of larger areas of samples so that 
hundreds of cells, as opposed to a handful, from one sample can be imaged. 
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The top-down approach described here is not capable of solving the puzzle of Se metabolism 
and the relationship between Se speciation and biological activity. However, the combination of XAS 
and XFM techniques is complimentary to traditional biochemical investigations and hyphenated 
techniques. The results we have presented here both conform to current understanding of 
metabolism and biological activity, while revealing Se and that pose more 
questions and provide new leads for research into the complex relationship between Se speciation 
biological activity. 
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